Analysts Turn Bullish on BioNTech Stock Amid Volatility

Core Viewpoint - BioNTech SE ADR (NASDAQ:BNTX) has seen a stock increase of 2.8% to $825.41 following an upgrade from Evercore ISI to "outperform" and a price target increase to $125 from $110, with the recent volatility seen as a buying opportunity for investors [1] Group 1: Stock Performance - BNTX shares are rebounding from a recent low, but remain below their 20-day moving average, which has been a source of pressure since October, leading to a 14.2% decline for the quarter, although still showing an 11.6% gain over the past nine months [2] Group 2: Options Market Sentiment - Options traders have exhibited increased bearish sentiment, as indicated by a 10-day put/call volume ratio of 4.85 at major exchanges, marking a higher level of bearishness than any readings from the past year [3] - The Schaeffer's put/call open interest ratio (SOIR) for BioNTech stands at 1.14, which is higher than 98% of annual readings, suggesting that a reversal of this pessimism could provide upward momentum for the stock [4]